A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS.
Ann Clin Transl Neurol
; 9(1): 50-66, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-35014217
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neurofilament Proteins
/
MAP Kinase Kinase Kinases
/
Protein Kinase Inhibitors
/
Amyotrophic Lateral Sclerosis
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Animals
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Clin Transl Neurol
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos